Reason for request

Inclusion

-


Clinical Benefit

Moderate

Moderate AB pending re-assessment of oral antihistamines.


Clinical Added Value

no clinical added value

No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form.